Disclosure Of Fair Value Measurement [Text Block]

Medicover - Filing #690784

Concept As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
Disclosure of fair value measurement [text block]
Disclosure of fair value measurement of assets [text block]
Disclosure of fair value measurement of assets [abstract]
Disclosure of fair value measurement of assets [line items]
Assets
1 831,7 EUR
1 684,3 EUR
Reconciliation of changes in fair value measurement, assets [abstract]
Disclosure of fair value measurement of liabilities [text block]
Disclosure of fair value measurement of liabilities [abstract]
Disclosure of fair value measurement of liabilities [line items]
Liabilities
1 320,9 EUR
1 122,2 EUR
Reconciliation of changes in fair value measurement, liabilities [abstract]
Disclosure of fair value measurement of equity [text block]
Disclosure of fair value measurement of equity [abstract]
Disclosure of fair value measurement of equity [line items]
Equity
5,108,000,000 EUR
963,000,000 EUR
361,000,000 EUR
4,586,000,000 EUR
1,272,000,000 EUR
6,000,000 EUR
304,000,000 EUR
667,000,000 EUR
208,000,000 EUR
4,747,000,000 EUR
13,000,000 EUR
7,000,000 EUR
1,413,000,000 EUR
782,000,000 EUR
5,621,000,000 EUR
EUR
5,176,000,000 EUR
153,000,000 EUR
445,000,000 EUR
4,587,000,000 EUR
492,000,000 EUR
304,000,000 EUR
509,000,000 EUR
355,000,000 EUR
EUR
4,480,000,000 EUR
301,000,000 EUR
4,000,000 EUR
551,000,000 EUR
451,000,000 EUR
4,587,000,000 EUR
4,835,000,000 EUR
89,000,000 EUR
Reconciliation of changes in fair value measurement, entity's own equity instruments [abstract]

Talk to a Data Expert

Have a question? We'll get back to you promptly.